In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae.
about
Combination therapy for extensively-drug resistant gram-negative bacteria.Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860
In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
In vitro Pharmacokinetics/Phar ...... oducing Klebsiella pneumoniae.
@ast
In vitro Pharmacokinetics/Phar ...... oducing Klebsiella pneumoniae.
@en
type
label
In vitro Pharmacokinetics/Phar ...... oducing Klebsiella pneumoniae.
@ast
In vitro Pharmacokinetics/Phar ...... oducing Klebsiella pneumoniae.
@en
prefLabel
In vitro Pharmacokinetics/Phar ...... oducing Klebsiella pneumoniae.
@ast
In vitro Pharmacokinetics/Phar ...... oducing Klebsiella pneumoniae.
@en
P2093
P2860
P356
P1476
In vitro Pharmacokinetics/Phar ...... oducing Klebsiella pneumoniae.
@en
P2093
Tianshui Niu
Tingting Xiao
Yonghong Xiao
P2860
P356
10.3389/FCIMB.2017.00246
P577
2017-06-16T00:00:00Z